跳至主要内容
临床试验/JPRN-jRCT2032220603
JPRN-jRCT2032220603招募中3 期

An SCT-based digital intervention among type 2 diabetes mellitus patients: an open-label randomized controlled trial

Waki Kayo0 个研究点目标入组 160 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • The study is targeting people with type 2 diabetes who are able to do exercise, leading to the following inclusion criteria. Patients who meet all of the criteria are eligible for the experiment.
  • 1. Diagnosed with type 2 diabetes (Diabetes mellitus that is thought to have developed as a result of insufficient insulin action due to environmental factors added to a genetic predisposition to insulin secretion and insulin resistance based on the history of present illness, without positive results for autoantibodies such as GAD, IAA, ICA, and IA-2 antibodies in the medical record)
  • 2. In the contemplation, preparation, or action stages of the transtheoretical model (determined by a brief questionnaire at the provisional registration (V0))
  • 3. HbA1c >= 7.5% and HbA1c <=10% at the provisional registration (V0)
  • 4. No change in antidiabetic medication (including insulin and GLP-1 receptor agonists) during the eight weeks before V0
  • 5. Age >= 18 at V0
  • 6. BP < 180/110 mmHg at V0
  • 7. eGFR of >= 45mL/min/1.73m2 confirmed at examination at least once in the 12 weeks before V0 or at V0
  • 8. Urine albumin creatinine ratio < 300mg/gCr on at least one occasion in the past year (52 weeks) or at V0
  • 9. BMI >= 22kg/m2 at V0
  • 10. No incidences in the 12 weeks before V0 of severe hypoglycemic attacks where assistance by others was required
  • 11.No symptoms of a possible hypoglycemic attack (including palpitations, tremors, dizziness, light-headedness, anxiousness, loss of consciousness, sweating, pale face, tachycardia, headache, drowsiness, blurred vision, convulsion) observed in the 12 weeks before V0
  • 12. Able to attend consultations at a specified time during the trial
  • 13. Fully informed about participation in this study, and have given free and voluntary written consent based on a thorough understanding of the study

排除标准

  • Patients who are unable to do exercise or do not need to do more exercise are not eligible for the present study, leading to the following exclusion criteria. Patients who meet at least one of the exclusion criteria are excluded from the experiment.
  • 1. In the precontemplation or maintenance stages of the transtheoretical model at V0
  • 2. Walked an average of >= 10,000 steps a day in the four weeks before V0 (must be verifiable by pedometer, etc.)
  • 3. Using a pacemaker
  • 4. Using continuous glucose monitoring (but do not exclude if self-monitoring of blood glucose or intermittently scanned-continuous glucose monitoring was conducted eight weeks or more before V0)
  • 5. Diagnosed with hyperthyroidism and have received treatment other than thyroid hormone replacement in the year before V0
  • 6. Diagnosed with a moderate to severe heart condition that requires exercise restriction as assessed by a physician
  • 7. Require exercise treatment restrictions as assessed by a physician at V0, decision made with reference to Cases in which exercise therapy should be prohibited or restricted in the Guidelines for Diabetes Treatment (Japan Diabetes Society, 2022-2023)
  • 8. Hb < 10g/dL at V0
  • 9. Serum albumin <= 3.0g/dL at V0
  • 10. Diagnosed with preproliferative retinopathy or retinopathy of a later stage within the year before V0
  • 11. Cannot undergo exercise treatment
  • 12. Pregnancy, including any possibility of or intention of pregnancy
  • 13. Participation in other trials at the time of registration (V2)
  • 14. Impaired cognitive function as determined by the investigator or sub investigator
  • 15. Any other reason that the patient is classified as unfit for participation by the investigator or sub investigator (a record must be kept of the reason the patient was determined to be inappropriate)

研究者

发起方
Waki Kayo

相似试验